Sanford Fargo Medical Center
Clinical research site in Fargo, North Dakota · 801 BROADWAY N, FARGO, ND 58122-4520 · (701) 234-2000 · Website
As of September 2026, 15 paid clinical trials are recruiting at Sanford Fargo Medical Center in Fargo, North Dakota. Active studies at this site cover conditions such as Breast Neoplasms, Extensive-Stage Small Cell Lung Cancer and Multiple Myeloma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Sanford Fargo Medical Center (15)
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy
General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
Get new-trial alerts for Sanford Fargo Medical Center
We'll email you whenever a new clinical trial starts recruiting at this research site in Fargo, ND. Unsubscribe anytime.
More research sites in Fargo
- Sanford Broadway Medical Center (79 trials)
- Sanford Roger Maris Cancer Center (63 trials)
- Essentia Health Cancer Center-South University Clinic (44 trials)
- Sanford Medical Center Fargo (14 trials)
- Sanford South University Medical Center (14 trials)
- Southpointe-Sanford Medical Center Fargo (13 trials)
- Sanford Health (9 trials)
- Lillestol Research (7 trials)
- Lillestol Research LLC (5 trials)
- Sanford Fargo Medical Center-Roger Maris Cancer Center (5 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Fargo, ND · North Dakota clinical trials